The updated coronavirus booster can now be used by children under 5 years old.

Following the FDA’s emergency approval on Wednesday, an updated coronavirus booster injection is now available for children under 5 years of age. Hours after the FDA action, Rochelle Walensky, director of the Centers for Disease Control and Prevention, recommended injections. — Last step prior to vaccination, the reconstituted booster is bivalent — It contains components of the original strain of the virus and the omicron sub-variants BA.4 and BA.5, which account for approximately 80 of the virus circulating in total. make up %. According to the U.S. Centers for Disease Control and Prevention (CDC), U.S. health officials say boosters that have been weakened since previous vaccinations need redesigned boosters to counteract new strains that are more contagious and evade immune defenses. The FDA has given it an emergency use authorization. Pfizer-BioNTech has updated booster injections for children 5-11 years old. The injection has already been approved for individuals 12 years of age and older. The agency has also approved the updated Moderna booster for children ages 6-17. It was previously approved for people over 18. “As children go back to school and people resume pre-epidemic behaviors and activities, FDA’s chief vaccine officer, Peter Marks, said in a statement, The risk of exposure is likely to increase: “Vaccination remains the most effective means of preventing the serious consequences of COVID-19, including hospitalization and death.” The Pfizer-BioNTech booster will be available next week, said James Campbell, professor of pediatrics at the University of Maryland Medical School. “Very good news for the family,” he said. He said some adults inaccurately minimize the risk of COVID-19 to children. “It is a mistake to believe that children are not ill or seriously ill from the coronavirus,” Campbell said. “It is a mistake to persistently compare the severity of COVID-19 in children with that of adults,” he said. “We need to compare COVID-19 with other pediatric diseases. It’s not clear whether the kids will get the booster back. Since the FDA rushed a bivalent booster for older adults at the end of August, absorption has been disappointingly slow – about 1,150 by Oct. 6, according to CDC data. Only 10,000 Americans have received the updated injection On Tuesday, White House covid-19 coordinator Ashish Jha asked Americans to bring a redesigned booster to start protection by Halloween. Jha said in a briefing on Tuesday that “the vaccine is up to date. “If you stay on the same day, get treatment, and develop a breakthrough infection, the risk of dying from the coronavirus is now near zero,” said administration officials. Administration officials said the cold weather could move people indoors and spread respiratory infections, causing COVID-19 patients to die. An analysis of CDC data from the American Academy of Pediatrics found that only 31% of children aged 5 to 11 received two doses of the vaccine, and 58% of children aged 12 to 17 years of age The series has been completed: Adults who received a booster dose with the original strain and components of Omicron BA.1 after the first two dose series or at least 2 months after the previous booster dose Targeted clinical studies FDA “consider the following data. Omicron mutations are relevant and supportive for vaccines containing components from the BA.4 and BA.5 strains,” the FDA said. The FDA has also scrutinized other data, including how the vaccine works in the real world. FDA officials said the approval of the 2-valent booster for children under five is months away. The federal government has purchased more than 170 million doses of bivalent coronavirus vaccine boosters for distribution as part of a campaign planned in the fall and early winter to enhance protection against circulating strains of the virus.
#updated #coronavirus #booster #children #years

Leave a Comment

Your email address will not be published. Required fields are marked *